483
Sinsin Pharmaceutical Co., Ltd.Sinsin Pharmaceutical Co., Ltd. – FDA 483, Feb 14, 2025
Record Details
An FDA inspection of Sinsin Pharmaceutical Co., Ltd. in Sejong, Korea, a drug manufacturer, revealed significant deficiencies in their quality systems. Observations included inadequate investigations into discrepancies and complaints, failure to follow stability testing programs, lack of component identity verification, and issues with equipment calibration and facility design. These findings indicate a serious lack of control over manufacturing processes and quality assurance.
View Company Profile
ID · 09afed3c-6fd0-46b6-acb8-ff5ecac5df45
Other documents for Sinsin Pharmaceutical Co., Ltd.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.